• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising
New Products
Gelatin, Soft Capsule Gelatin, Hard Capsule Gelatin, Pharmaceutical Gelatin-Foodmate
Neohesperidin
Advantame
Cleanroom Bench Horizontal Laminar Flow Hood Airflow Clean Bench
Pharma and Food Grade, USP/FCC Neotame Sweetener E961
Trilobatin

Serum Institute to start manufacturing Sputnik vaccine in September

expresspharmaJuly 14, 2021

Tag: SII , RDIF , Sputnik vaccine

Serum Institute of India (SII) will start production of Sputnik vaccine at the company’s facilities in September, Russian Direct Investment Fund (RDIF) said.

“The first batch of Sputnik vaccine is expected to be produced at SII’s facilities in September,” RDIF said in a statement.

The parties intend to produce over 300 million doses of the vaccine in India per year, it added.

“As part of the technical transfer process, SII has already received cell and vector samples from the Gamaleya Center. With their import approved by the Drug Controller General of India (DCGI), the cultivation process has begun,” RDIF said.

Previous:Lupin launches Tavaborole Topical Solution in US

Next:US FDA adds new warning on J&J COVID-19 vaccine for Guillain-Barre´ syndrome

Related News

Everest Medicines Announces Acceptance of the New Drug Application for VELSIPITY

Everest Medicines LimitedDecember 20, 2024

Everest Medicines announced NMPA acceptance of NDA for VELSIPITY(R) (etrasimod) to treat moderately to severely active UC.

Manulife Hong Kong Partners with New Frontier Group to Enhance Cross-Border Healthcare Services

PRNewswireDecember 12, 2024

Menarini Group and MEDSIR Present the Phase III Study ADELA: A New Therapeutic Strategy for Advanced Breast Cancer

PRNewswireDecember 12, 2024

Serum Institute to start manufacturing Sputnik vaccine in September | Pharmasources.com

Core8 Group and MedArmor to Pioneer Vietnam's First AI x ESG Hospital

PRNewswireDecember 12, 2024

Core8 Group, an Australian leader in high-tech and biotech innovation, has unveiled plans to develop Vietnam's first AI x ESG Hospital, marking a significant milestone in healthcare transformation.

You may like
More>>

Sida Cordifolia Extract Powder 5%

Sida Cordifolia Extract Powder 5%
Tinospora Cordifollisa Extract Powder

Tinospora Cordifollisa Extract Powder
Losartan potassium (ProcessII)

Losartan potassium (ProcessII)
Anredera cordifolia extract

Anredera cordifolia extract
100%Nutramax Supplier -sambucus williamsii hance extract10:1

100%Nutramax Supplier -sambucus williamsii hance extract10:1
Tinospora Cordifolia Extract Powder

Tinospora Cordifolia Extract Powder
Nephrolepis Cordifolia Presl Auriculata Tuberous Rhizome Silk Napkin Rings All-Grass Of Hirsute Swor

Nephrolepis Cordifolia Presl Auriculata Tuberous Rhizome Silk Napkin Rings All-Grass Of Hirsute Swor
Herba Cirsii Extract

Herba Cirsii Extract
elder Sambucus williamsii Sambucus nigra Williams Elder Twig elderberry extract elder Sambucus willi

elder Sambucus williamsii Sambucus nigra Williams Elder Twig elderberry extract elder Sambucus willi
Cosmosiin 98%

Cosmosiin 98%

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service